MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
Diagnosis and treatment of prostate cancer (PCа) are associated with the serum level of prostate specific antigen (PSA). However, certain prostate diseases such as benign prostatic hyperplasia (BPH) and prostatitis can also affect PSA levels. The low specificity and sensitivity of PSA leads to a &qu...
Saved in:
| Main Authors: | Z. M. Akhokhov, R. S. Ismailov, M. I. Kogan |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ministry of Health of Russian Federation, Rostov State Medical University, State Budget Educational Institute of Higher Professional Education
2023-10-01
|
| Series: | Вестник урологии |
| Subjects: | |
| Online Access: | https://www.urovest.ru/jour/article/view/760 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of novel biomarkers of renal dysfunction associated with lower urinary tract symptoms in men with benign prostatic hyperplasia
by: V. Yu. Startsev, et al.
Published: (2024-11-01) -
Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care, Port Harcourt, Nigeria
by: A.A. Bock-Oruma, et al.
Published: (2013-10-01) -
The clinical signifi cance of urethral sphincter hyperkinesis in the treatment of benign prosta???? c hyperplasia
by: I. I. Belousov
Published: (2019-02-01) -
Silodosin — a safer alpha-blocker targeting benign prostatic hyperplasia
by: Karen Koch
Published: (2015-09-01) -
Antibiotic resistance of microorganisms isolated from the urine of patients before surgical treatment for benign prostatic hyperplasia: results from a 7-year single-center study
by: M. I. Kogan, et al.
Published: (2024-04-01)